All extended-release metformin treatment regimens produced significant decreases in A1C levels that were similar to those with the comparator, immediate-release metformin, a widely used and highly ...
Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE ™ XR (saxagliptin and metformin HCl extended-release), ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
PRINCETON, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™ ...
From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an ...
Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg ...
The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity. Viona Pharmaceuticals, Inc. is voluntarily recalling 23 lots of ...
Two additional manufacturers have issued voluntary recalls of a popular diabetes drug after determining it contained unacceptably high levels of a cancer-causing agent. Marksans Pharma Ltd. and Sun ...
Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...
A randomized, double-blind, active-controlled, fixed-dose, phase III clinical trial was conducted at 85 centers in the U.S. between August 2001 and October 2003. The study protocol was approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback